D-0397-2025 Class II Ongoing

Recalled by ACCORD HEALTHCARE, INC. — Raleigh, NC

FDA drug recall D-0397-2025 was initiated by ACCORD HEALTHCARE, INC. on Apr 10, 2025 and is designated Class II. Reason for recall: Subpotent The recall status is ongoing. Affected quantity: 18,984 Bottles.

Recall details

Product Type
Drugs
Report Date
May 7, 2025
Initiation Date
Apr 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18,984 Bottles

Product description

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 90 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-452-15

Reason for recall

Subpotent

Distribution pattern

Nationwide US.

Code information

Lot # D2400725, Exp Date: 03/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0397-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0397-2025. Report a data issue: hello@regdatalab.com.